eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer
Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
- Bernhard Mlecnik1,2,3,*,
- Gabriela Bindea1,2,3,*,
- Helen K. Angell1,2,3,
- Maria Stella Sasso1,2,3,
- Anna C. Obenauf4,
- Tessa Fredriksen1,2,3,
- Lucie Lafontaine1,2,3,
- Amelie M. Bilocq1,2,3,
- Amos Kirilovsky1,2,3,
- Marie Tosolini1,2,3,
- Maximilian Waldner1,2,3,5,
- Anne Berger6,
- Wolf Herman Fridman2,3,7,
- Arash Rafii8,
- Viia Valge-Archer9,
- Franck Pagès1,2,3,10,
- Michael R. Speicher4 and
- Jérôme Galon1,2,3,†
- 1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
- 2Université Paris Descartes, Paris F-75006, France.
- 3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
- 4Institute of Human Genetics, Medical University of Graz, Graz A-8036, Austria.
- 5University of Erlangen-Nuremberg, Erlangen G-91054, Germany.
- 6Assistance Publique-Hopitaux de Paris, Department of General and Digestive Surgery, Paris F-75015, France.
- 7INSERM UMRS1138, Team 13, Paris F-75006, France.
- 8Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha Q-10065, Qatar.
- 9MedImmune, Cambridge CG21 6GH, UK.
- 10Department of Immunology, Georges Pompidou European Hospital, Paris F-75015, France.
- ↵†Corresponding author. E-mail: jerome.galon{at}crc.jussieu.fr
-
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Translational Medicine 19 Mar 2014:
Vol. 6, Issue 228, pp. 228ra37
DOI: 10.1126/scitranslmed.3007240
Vol. 6, Issue 228, pp. 228ra37
DOI: 10.1126/scitranslmed.3007240
Bernhard Mlecnik
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Gabriela Bindea
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Helen K. Angell
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Maria Stella Sasso
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Anna C. Obenauf
4Institute of Human Genetics, Medical University of Graz, Graz A-8036, Austria.
Tessa Fredriksen
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Lucie Lafontaine
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Amelie M. Bilocq
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Amos Kirilovsky
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Marie Tosolini
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Maximilian Waldner
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
5University of Erlangen-Nuremberg, Erlangen G-91054, Germany.
Anne Berger
6Assistance Publique-Hopitaux de Paris, Department of General and Digestive Surgery, Paris F-75015, France.
Wolf Herman Fridman
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
7INSERM UMRS1138, Team 13, Paris F-75006, France.
Arash Rafii
8Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha Q-10065, Qatar.
Viia Valge-Archer
9MedImmune, Cambridge CG21 6GH, UK.
Franck Pagès
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
10Department of Immunology, Georges Pompidou European Hospital, Paris F-75015, France.
Michael R. Speicher
4Institute of Human Genetics, Medical University of Graz, Graz A-8036, Austria.
Jérôme Galon
1INSERM UMRS1138, Laboratory of Integrative Cancer Immunology, Paris F-75006, France.
2Université Paris Descartes, Paris F-75006, France.
3Cordeliers Research Centre, Université Pierre et Marie Curie Paris 6, Paris F-75006, France.
Submit a Response to This Article
No eLetters have been published for this article.